SummerHaven Investment Management LLC Takes $828,000 Position in Viemed Healthcare, Inc. $VMD

SummerHaven Investment Management LLC acquired a new position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 121,936 shares of the company’s stock, valued at approximately $828,000. SummerHaven Investment Management LLC owned about 0.31% of Viemed Healthcare at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. AQR Capital Management LLC acquired a new stake in Viemed Healthcare in the first quarter valued at $90,000. Cardinal Point Capital Management ULC purchased a new position in shares of Viemed Healthcare in the 2nd quarter valued at about $128,000. Intech Investment Management LLC increased its holdings in shares of Viemed Healthcare by 14.4% in the 2nd quarter. Intech Investment Management LLC now owns 18,612 shares of the company’s stock valued at $129,000 after acquiring an additional 2,349 shares during the last quarter. Invesco Ltd. raised its position in shares of Viemed Healthcare by 25.5% during the 2nd quarter. Invesco Ltd. now owns 18,652 shares of the company’s stock worth $129,000 after acquiring an additional 3,795 shares in the last quarter. Finally, Marshall Wace LLP purchased a new stake in Viemed Healthcare during the second quarter worth approximately $147,000. Institutional investors and hedge funds own 74.24% of the company’s stock.

Viemed Healthcare Price Performance

Shares of NASDAQ VMD opened at $7.38 on Thursday. The stock has a market cap of $280.59 million, a P/E ratio of 22.36 and a beta of 1.25. Viemed Healthcare, Inc. has a twelve month low of $5.93 and a twelve month high of $8.42. The stock has a 50 day moving average of $7.19 and a two-hundred day moving average of $6.88. The company has a current ratio of 1.13, a quick ratio of 1.01 and a debt-to-equity ratio of 0.14.

Viemed Healthcare (NASDAQ:VMD) last announced its earnings results on Wednesday, November 5th. The company reported $0.09 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.09. The business had revenue of $71.91 million for the quarter, compared to analyst estimates of $72.00 million. Viemed Healthcare had a net margin of 5.34% and a return on equity of 9.95%.

Wall Street Analyst Weigh In

Several equities analysts have commented on VMD shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Viemed Healthcare in a research note on Monday, December 29th. Wall Street Zen cut shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 10th. Finally, Zacks Research raised shares of Viemed Healthcare to a “hold” rating in a research report on Thursday, January 8th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company has a consensus rating of “Hold”.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.